GLP Watchdog

Hims vs Wisp

Hims has an open FDA warning letter dated September 9, 2025. Wisp has none. No price lines up like for like: Hims and Wisp publish prices for different products.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Hims / Wisp

Hims logo

Hims

6.7/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$149/moBrand-name semaglutide pill, medication only, membership extra
$225/moCompounded oral semaglutide
States
All 50 states
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Hims
Visit Wisp

Neither Hims nor Wisp pays us. Links to them earn nothing. Scores: Hims 6.7, Wisp 7.1. How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Wisp has none.

  2. 02

    Wisp names no compounding pharmacy in our record. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like: Hims and Wisp publish prices for different products.

  4. 04

    Only Hims lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill. Only Wisp lists a price for compounded oral semaglutide.

  5. 05

    Hims covers 11 states Wisp does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Hims

Wisp

Brand-name semaglutide pen

$199/mo

medication only, membership extra; not compared

Not sold or not priced
Brand-name tirzepatide pen

$299/mo

medication only, membership extra; not compared

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$225/mo

$2,700 a year

Brand-name semaglutide pill

$149/mo

medication only, membership extra; not compared

Not sold or not priced
Foundayo (orforglipron) pill

$149/mo

medication only, membership extra; not compared

Not sold or not priced
Price includes
Medication
Medication, shipping
Billed separately
Clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
Monthly membership, auto-renews
Not stated
Refunds
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
All sales are final
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Hims: October 17, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Hims

6.7/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Wisp does not price
  • Lists 50 states against 39
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

The case for Wisp

7.1/10
  • No FDA warning letter on record
  • Sells compounded oral semaglutide, which Hims does not price
  • Names no compounding pharmacy
Visit Wisp

Scores

Hims 6.7 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
7.5

Accessibility10%

10.0A
vs
B
8.2

Support10%

3.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

Hims vs Wisp: questions

Hims has an open FDA warning letter dated September 9, 2025. Wisp has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Wisp names no compounding pharmacy in our record. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like: Hims and Wisp publish prices for different products. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed. Wisp states you can cancel at any time; refunds: all sales are final.
Neither Hims nor Wisp pays us. Links to them earn nothing. Scores: Hims 6.7, Wisp 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks